California Assembly Bill 2013 (AB 2013), known as the Generative Artificial Intelligence: Training Data Transparency Act, was signed into law on September 28, 2024, and is set to take effect on January 1, 2026…
more
/ Intellectual Property, Privacy, Science, Computers, & Technology
Businesses that award shares, options or other securities to UK employees, directors or officer holders need to be aware of the July 6 deadline to submit an Employment Related Securities (ERS) annual return to HM Revenue &…
more
/ Business Organizations, Labor & Employment Law
On June 5, 2025, the UK Government announced the result of their recent consultation process regarding their plans to bring carried interest within the income tax regime from April 2026, subject to an effective tax rate of…
more
/ Finance & Banking, Taxation
In recent remarks delivered at the U.S. Chamber of Commerce Capital Markets Summit, Acting Comptroller of the Currency, Rodney E. Hood, outlined the OCC’s strategic priorities for building a resilient and revitalized federal…
more
/ Finance & Banking, Science, Computers, & Technology
On May 22, 2025, the FTC filed a proposed stipulated order in the District Court for the Middle District of Florida to resolve allegations that several individuals and the student loan debt relief companies that they operated…
more
/ Consumer Protection, Finance & Banking
On May 6, 2025, with almost no discernible press or public announcements, the Dental Trade Alliance (DTA) – a trade association of dental suppliers and service providers – issued a revised and restated U.S. Code of Ethics (the…
more
/ Commercial Law & Contracts, Health
On May 21, 2025, Sandoz announced the commercial launch in Europe of its PYZCHIVA® (ustekinumab) autoinjector, “the first ustekinumab biosimilar in Europe commercially available in an autoinjector.”…
more
/ Commercial Law & Contracts, Science, Computers, & Technology
Samsung Bioepis Co., Ltd. has secured marketing approval in Korea for XBRYK, its biosimilar to Amgen’s bone cancer drug XGEVA, used to prevent fractures in those with bone metastases from solid tumors or multiple myeloma and to…
more
/ Health, International Law & Trade
We previously reported on an uptick in the passage of state drug price transparency legislation. What follows is an update to that report. As of April 2025, approximately 23 states had passed drug price transparency laws…
more
/ Administrative Law, Consumer Protection, Health
In the last month, the FDA has granted interchangeability status to additional adalimumab biosimilars. Biosimilars with an interchangeable designation may be substituted for the reference product at the pharmacy without…
more
/ Health, Intellectual Property, Science, Computers, & Technology
Prescription Drug Affordability Boards (PDABs) are becoming a larger part of the state drug price regulatory landscape. The boards are regulatory bodies that review the affordability and cost of specific prescription drugs…
more
/ Administrative Law, Constitutional Law, Health
On May 27, 2025, Fresenius Kabi (“Fresenius”) announced that the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) had issued positive opinions for Fresenius’s two denosumab biosimilar candidates…
more
/ Health, Intellectual Property, Science, Computers, & Technology
Over the past month, the Consumer Financial Protection Bureau (CFPB) took a slew of actions with the apparent aim to decrease the CFPB’s regulatory authority.
On May 14, 2025, the CFPB proposed rescinding the “NBR Rule”…
more
/ Consumer Protection, Finance & Banking
In this horizon scan for private investment funds, which is aimed at managers based in Europe, we have set out the some of the principal legal and regulatory-focused developments to look out for in the coming months…
more
/ Finance & Banking, Securities Law
Private equity firms’ ability to invest in medical practices in Oregon may be sharply curtailed under a bill passed this week by the Oregon legislature. On May 29th, a bipartisan supermajority in the Oregon House passed Senate…
more
/ Finance & Banking, Health
